Mol Neurobiol 54:55505562 Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged
These ranges underscore that protein needs are higher for active individuals or those changing their weight, and more modest for maintenance
GLP1 analogues work on the gut-brain hormone axis, the powerful mechanism that controls our hunger and very importantly our satiety, sending messages to our brain that we are full, making us less hungry and thereby leading to less food being consumed
But efficacy is only one piece of the picture
For a medication that requires refrigeration, this raises legitimate potency questions
In other words, if you have not experienced significant GI side effects by week 20, you are unlikely to develop them going forward on a stable dose